01 1Sandoz B2B
01 1CLAVULANATE POTASSIUM
01 1Switzerland
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2018-07-13
Pay. Date : 2018-06-21
DMF Number : 14679
Submission : 2000-01-19
Status : Active
Type : II
20
Lek Pharmaceuticals Dd, based in Switzerland, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for A global leader in antibiotics.
One of their notable products is CLAVULANATE POTASSIUM, with a corresponding US DMF Number 14679.
Remarkably, this DMF maintains an Active status since its submission on January 19, 2000, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 13, 2018, and payment made on June 21, 2018, indicating their dedication to facilitating drug approvals, Categorized as Type II
